The Agreement Will Ensure Logistical Cost
Savings and Accelerated Development of Applied UV’s Next Generation
Products
Applied UV, Inc. (Nasdaq CM: AUVI) (“Applied UV” or the
“Company”), a pathogen elimination technology company, announced
that it has signed a strategic manufacturing and related services
agreement with Canon Virginia, Inc., (“CVI”) a global
manufacturing, engineering and technical operation for the Canon
family and a wholly owned subsidiary of Canon U.S.A, Inc. The
agreement establishes CVI’s status as the primary manufacturer,
assembler and logistical authority for Applied UV’s suite of air
purification solutions. The Manufacturing Agreement, the first of a
series of anticipated agreements, enables the Company to leverage
the resources of CVI’s two million-square-foot state-of-the-art
engineering, manufacturing and distribution facility.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20221216005028/en/
Airocide Air Purifier (Graphic: Applied
UV, Inc.)
"In anticipation of the expanded use globally of our Airocide
and Scientific Air fixed and mobile air purification solutions,
this strategic relationship is one which I value more than most,"
said Max Munn, President & Director of Applied UV. "Over the
past three years, supply chain and logistics disruptions have
impacted operations for companies globally, so consolidating and
bringing our manufacturing processes on shore with one company was
a top priority.”
Applied UV plans to leverage CVI’s almost 40 years of innovative
and efficient production methods to manufacture the Company’s
patented, FDA Class II Listed Airocide PCO commercial and consumer
devices, as well as the patented advanced Activated Carbon UVC and
HEPA Mobile disinfection Scientific Air portfolio.
“Financially speaking, CVI’s breadth of in-house capabilities
and supply-chain efficiencies should translate into untold short
and longer-term production, logistical cost savings and accelerated
development of our next generation products,” said Max Munn,
President, Founder and a Director of Applied UV. “By reducing
manufacturing execution risk, we will be able to focus solely on
sales and marketing.”
Applied UV also plans to collaborate with Canon Financial
Services, Inc. to enable better cash flow management in regard to
its growing supply chain requirements. Further, the Company will
look to work with CVI’s affiliates extensive field support team to
promote the sale of the Company’s products, as well as service
capabilities.
Canon operates under the philosophy of Kyosei, which means,
‘living and working together for the common good,’” said Shingo
Shigeta, President and Chief Executive Officer of CVI. “We look
forward to working together with the Applied UV team to improve the
quality of indoor air globally by offering our manufacturing,
R&D and process expertise to the current and next generation
Applied UV family of best-in-class air and surface disinfection
portfolio.”
About Canon Virginia, Inc.
Located in Newport News, Va., Canon Virginia, Inc. serves as the
Canon manufacturing, engineering, recycling and technical support
center for the Americas. Canon Virginia produces new products using
advanced manufacturing methodologies while also serving as a
factory service center providing expert customer service in the
repair and refurbishment of Canon products. Canon Virginia’s
manufacturing services extend to injection mold making, contract
manufacturing, medical contract manufacturing and aftermarket
services. For more information, call 1-866-99-CANON or visit
https://www.cvi.canon.com/manufacturing-services/.
About Applied UV
Applied UV, Inc. (“AUVI”) develops and acquires proprietary
infection prevention and control technology in the healthcare,
commercial & public venue, food processing/storage, cannabis,
and education, vertical markets. AUVI has two wholly owned
subsidiaries - SteriLumen, Inc. (“SteriLumen”) and Munn Works, LLC
(“Munn Works”). Sterilumen owns and markets a portfolio of products
with advanced pathogen elimination technology, branded Airocide® by
Sterilumen, Scientific Air™ by Sterilumen, Airoclean™ 420 by
Sterilumen, and Lumicide™ by Sterilumen.
Leading organizations globally rely on AUVI’s air purification
systems to completely eliminate airborne and surface infections,
mold, bacteria, allergens and other contaminants. Our customers
include Kaiser Permanente, NY Health+Hospitals, Baptist Health
South Florida, Boston Red Sox’s Fenway Park, JetBlue Park, France’s
Palace of Versailles, Invited Clubs, Whole Foods, Del Monte Foods,
U.S. Department of Veterans Affairs, and more.
Scientifically proven to reduce Healthcare Acquired Infections
(HAI), Scientific Air™ offers a proprietary 3-stage technology
integrating HEPA filters, ultraviolet germicidal light chamber and
active carbon substrate.
For information on Applied UV, Inc., and its subsidiaries,
please visit the following websites: https://www.applieduvinc.com/
https://www.sterilumen.com https://airoclean420.com/
Forward-Looking Statements
The information contained herein may contain “forward‐looking
statements.” Forward‐looking statements reflect the current view
about future events. When used in this press release, the words
“anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,”
“plan,” or the negative of these terms and similar expressions, as
they relate to us or our management, identify forward‐looking
statements. Such statements include, but are not limited to,
statements contained in this press release relating to the view of
management of Applied UV concerning its business strategy, future
operating results and liquidity and capital resources outlook.
Forward‐looking statements are based on the Company’s current
expectations and assumptions regarding its business, the economy
and other future conditions. Because forward–looking statements
relate to the future, they are subject to inherent uncertainties,
risks and changes in circumstances that are difficult to predict.
The Company’s actual results may differ materially from those
contemplated by the forward‐looking statements. They are neither
statements of historical fact nor guarantees of assurance of future
performance. We caution you therefore against relying on any of
these forward‐looking statements. Factors or events that could
cause the Company’s actual results to differ may emerge from time
to time, and it is not possible for the Company to predict all of
them. The Company cannot guarantee future results, levels of
activity, performance, or achievements. Except as required by
applicable law, including the securities laws of the United States,
the Company does not intend to update any of the forward‐looking
statements to conform these statements to actual results.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221216005028/en/
For additional Company Information: Max Munn, President,
Founder and a Director Applied UV Inc. m.munn@sterilumen.com
Contact: Brett Maas, Managing Principal Hayden IR
brett@haydenir.com (646) 536-7331
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From Apr 2024 to May 2024
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From May 2023 to May 2024